BMRN logo

BioMarin Pharmaceutical (BMRN) Interest expense

annual interest expense:

$12.34M-$1.49M(-10.74%)
December 31, 2024

Summary

  • As of today (July 1, 2025), BMRN annual interest expense is $12.34 million, with the most recent change of -$1.49 million (-10.74%) on December 31, 2024.
  • During the last 3 years, BMRN annual interest expense has fallen by -$2.40 million (-16.31%).
  • BMRN annual interest expense is now -71.74% below its all-time high of $43.66 million, reached on December 31, 2018.

Performance

BMRN Interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

quarterly interest expense:

$2.86M+$613.00K(+27.24%)
March 31, 2025

Summary

  • As of today (July 1, 2025), BMRN quarterly interest expense is $2.86 million, with the most recent change of +$613.00 thousand (+27.24%) on March 31, 2025.
  • Over the past year, BMRN quarterly interest expense has dropped by -$684.00 thousand (-19.28%).
  • BMRN quarterly interest expense is now -74.48% below its all-time high of $11.22 million, reached on June 30, 2018.

Performance

BMRN quarterly interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

TTM interest expense:

$11.65M-$684.00K(-5.54%)
March 31, 2025

Summary

  • As of today (July 1, 2025), BMRN TTM interest expense is $11.65 million, with the most recent change of -$684.00 thousand (-5.54%) on March 31, 2025.
  • Over the past year, BMRN TTM interest expense has dropped by -$2.01 million (-14.73%).
  • BMRN TTM interest expense is now -73.36% below its all-time high of $43.75 million, reached on September 30, 2018.

Performance

BMRN TTM interest expense Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

Interest expense Formula

Interest Expense = Carrying Value of Debt X Effective Interest Rate

BMRN Interest expense Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-10.7%-19.3%-14.7%
3 y3 years-16.3%-24.8%-21.0%
5 y5 years-42.4%-58.6%-47.7%

BMRN Interest expense Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-16.3%at low-38.8%+94.8%-25.3%at low
5 y5-year-55.1%at low-70.2%+94.8%-59.7%at low
alltimeall time-71.7%+84.7%-74.5%+518.4%-73.4%+235.6%

BMRN Interest expense History

DateAnnualQuarterlyTTM
Mar 2025
-
$2.86M(+27.2%)
$11.65M(-5.5%)
Dec 2024
$12.34M(-10.7%)
$2.25M(-24.2%)
$12.34M(-2.7%)
Sep 2024
-
$2.97M(-17.0%)
$12.68M(-6.0%)
Jun 2024
-
$3.57M(+0.8%)
$13.49M(-1.3%)
Mar 2024
-
$3.55M(+37.1%)
$13.67M(-1.1%)
Dec 2023
$13.82M(+0.1%)
$2.59M(-31.5%)
$13.82M(+8.8%)
Sep 2023
-
$3.78M(+0.6%)
$12.71M(-6.6%)
Jun 2023
-
$3.75M(+1.4%)
$13.61M(-0.8%)
Mar 2023
-
$3.70M(+151.9%)
$13.71M(-0.7%)
Dec 2022
$13.81M(-6.3%)
$1.47M(-68.6%)
$13.81M(-11.4%)
Sep 2022
-
$4.68M(+21.2%)
$15.60M(+5.5%)
Jun 2022
-
$3.86M(+1.4%)
$14.79M(+0.3%)
Mar 2022
-
$3.81M(+17.0%)
$14.75M(+0.0%)
Dec 2021
$14.74M(-46.3%)
$3.25M(-15.9%)
$14.74M(+2.3%)
Sep 2021
-
$3.87M(+1.4%)
$14.41M(-28.4%)
Jun 2021
-
$3.82M(+0.3%)
$20.14M(-15.6%)
Mar 2021
-
$3.80M(+30.3%)
$23.85M(-11.5%)
Dec 2020
$27.48M(+28.2%)
$2.92M(-69.6%)
$26.96M(-6.8%)
Sep 2020
-
$9.60M(+27.5%)
$28.94M(+29.9%)
Jun 2020
-
$7.53M(+8.8%)
$22.28M(+5.5%)
Mar 2020
-
$6.92M(+41.2%)
$21.11M(+0.9%)
Dec 2019
$21.43M(-50.9%)
$4.90M(+66.8%)
$20.92M(-21.9%)
Sep 2019
-
$2.94M(-53.8%)
$26.79M(-23.4%)
Jun 2019
-
$6.36M(-5.5%)
$34.97M(-12.2%)
Mar 2019
-
$6.73M(-37.5%)
$39.83M(-8.8%)
Dec 2018
$43.66M(+12.0%)
$10.76M(-3.2%)
$43.66M(-0.2%)
Sep 2018
-
$11.12M(-0.9%)
$43.75M(+3.2%)
Jun 2018
-
$11.22M(+6.3%)
$42.37M(+5.1%)
Mar 2018
-
$10.56M(-2.7%)
$40.31M(+3.4%)
Dec 2017
$38.98M(+7.9%)
$10.85M(+11.3%)
$38.98M(+5.4%)
Sep 2017
-
$9.75M(+6.5%)
$36.97M(+1.6%)
Jun 2017
-
$9.15M(-0.9%)
$36.38M(+0.1%)
Mar 2017
-
$9.23M(+4.4%)
$36.35M(+0.6%)
Dec 2016
$36.13M
$8.84M(-3.4%)
$36.13M(+0.9%)
DateAnnualQuarterlyTTM
Sep 2016
-
$9.15M(+0.4%)
$35.80M(+1.5%)
Jun 2016
-
$9.12M(+1.1%)
$35.27M(-0.2%)
Mar 2016
-
$9.02M(+6.0%)
$35.33M(+1.1%)
Dec 2015
$34.95M(+4.9%)
$8.51M(-1.3%)
$34.95M(+0.4%)
Sep 2015
-
$8.62M(-6.1%)
$34.81M(+1.0%)
Jun 2015
-
$9.18M(+6.3%)
$34.48M(+2.4%)
Mar 2015
-
$8.64M(+3.2%)
$33.68M(+1.1%)
Dec 2014
$33.31M(+255.5%)
$8.37M(+1.0%)
$33.31M(+4.7%)
Sep 2014
-
$8.29M(-1.2%)
$31.81M(+32.6%)
Jun 2014
-
$8.39M(+1.5%)
$23.98M(+48.7%)
Mar 2014
-
$8.26M(+20.3%)
$16.13M(+72.1%)
Dec 2013
$9.37M(+40.3%)
$6.87M(+1383.6%)
$9.37M(+169.9%)
Sep 2013
-
$463.00K(-12.8%)
$3.47M(-28.3%)
Jun 2013
-
$531.00K(-64.8%)
$4.85M(-22.3%)
Mar 2013
-
$1.51M(+55.6%)
$6.24M(-6.6%)
Dec 2012
$6.68M(-20.6%)
$970.00K(-47.2%)
$6.68M(-12.0%)
Sep 2012
-
$1.84M(-4.6%)
$7.59M(-4.2%)
Jun 2012
-
$1.93M(-1.1%)
$7.92M(-3.4%)
Mar 2012
-
$1.95M(+3.7%)
$8.19M(-2.6%)
Dec 2011
$8.41M(-22.3%)
$1.88M(-13.4%)
$8.41M(-9.4%)
Sep 2011
-
$2.17M(-1.5%)
$9.28M(-8.3%)
Jun 2011
-
$2.20M(+1.8%)
$10.12M(-4.1%)
Mar 2011
-
$2.16M(-21.2%)
$10.55M(-2.5%)
Dec 2010
$10.82M(-23.2%)
$2.75M(-8.7%)
$10.82M(+0.3%)
Sep 2010
-
$3.01M(+14.2%)
$10.79M(+1.2%)
Jun 2010
-
$2.63M(+8.5%)
$10.66M(-14.2%)
Mar 2010
-
$2.43M(-10.5%)
$12.43M(-11.8%)
Dec 2009
$14.09M(-14.1%)
$2.71M(-5.7%)
$14.09M(-8.9%)
Sep 2009
-
$2.88M(-34.6%)
$15.47M(-7.3%)
Jun 2009
-
$4.40M(+7.8%)
$16.69M(+2.0%)
Mar 2009
-
$4.09M(-0.2%)
$16.37M(+33.3%)
Dec 2008
$16.39M
$4.10M(-0.2%)
$12.28M(+50.0%)
Sep 2008
-
$4.11M(+0.6%)
$8.19M(+100.6%)
Jun 2008
-
$4.08M
$4.08M

FAQ

  • What is BioMarin Pharmaceutical annual interest expense?
  • What is the all time high annual interest expense for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical annual interest expense year-on-year change?
  • What is BioMarin Pharmaceutical quarterly interest expense?
  • What is the all time high quarterly interest expense for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical quarterly interest expense year-on-year change?
  • What is BioMarin Pharmaceutical TTM interest expense?
  • What is the all time high TTM interest expense for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical TTM interest expense year-on-year change?

What is BioMarin Pharmaceutical annual interest expense?

The current annual interest expense of BMRN is $12.34M

What is the all time high annual interest expense for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high annual interest expense is $43.66M

What is BioMarin Pharmaceutical annual interest expense year-on-year change?

Over the past year, BMRN annual interest expense has changed by -$1.49M (-10.74%)

What is BioMarin Pharmaceutical quarterly interest expense?

The current quarterly interest expense of BMRN is $2.86M

What is the all time high quarterly interest expense for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high quarterly interest expense is $11.22M

What is BioMarin Pharmaceutical quarterly interest expense year-on-year change?

Over the past year, BMRN quarterly interest expense has changed by -$684.00K (-19.28%)

What is BioMarin Pharmaceutical TTM interest expense?

The current TTM interest expense of BMRN is $11.65M

What is the all time high TTM interest expense for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high TTM interest expense is $43.75M

What is BioMarin Pharmaceutical TTM interest expense year-on-year change?

Over the past year, BMRN TTM interest expense has changed by -$2.01M (-14.73%)
On this page